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Lambdoid phages suppress transcription termination to fully express their genes.
Antitermination of early gene expression in most lambdoid phages is mediated by an
interaction between the N protein and a number of host-encoded factors. Bacteriophage
HK022 does not rely on a protein for antitermination. To promote full expression of early
phage genes, the transcripts of the HK022 put sites interact directly with RNA
polymerase to convert it to a termination resistant form. Bacteriophage HK639 also uses
RNA-mediated antitermination. However, it only possesses a single put-like element in
its left operon. Because most lambdoid phages, including HK022, have antiterminator
elements in each of their early operons, the presence of a single antitermination site in
HK639 was unexpected.
We have shown that host genes involved in promoting protein-mediated
antitermination are not required for HK639 growth. We have also shown that expression
of the left operon is essential for lytic growth. Replacement of the left operon promoter,
PL, and the putL antitermination sequence prevented HK639 phage release. A similar
construct that only replaced putL also prevented phage release. These results suggest that
antitermination is required for HK639 excision and/or lytic growth. To distinguish
between a defect in phage excision versus a defect in lytic growth, the mutations were
crossed onto lytically growing phage. Recombinant phages could not be recovered which
suggests a defect in lytic growth is preventing phage release.
viii

Additional replacements of left operon sequences suggest that antitermination is
not the only requirement for lytic growth. A 2,161bp deletion (HK639 genome
coordinates 30,888-33,048) and a 1,736bp deletion (HK639 genome coordinates 29,15230,887) downstream of the HK639 putL site also prevented phage release, whereas a
1,746bp deletion (HK639 genome coordinates 29,151-27,406) did not. These results
suggest that the deleted HK639 left operon sequences are required for lytic growth.
BLAST analysis did not provide insight into the function of the deleted genes. Although
the function of many of the HK639 left operon genes is unknown, their importance in
phage growth can now be verified by complementation analysis. Our results suggest that
HK639 may use a novel mechanism to control the expression of its early genes.

ix

INTRODUCTION
Bacteriophages (phages) are viruses that infect bacteria. They are ubiquitous and
are proposed to be the most abundant entity in the biosphere. Outnumbering their
bacterial hosts by a factor of ten, the global population of phage particles is estimated to
be in excess of 1031 (1). Since their discovery in 1915 and 1917 by Frederick Twort and
Felix d’Herelle respectively, phage have been studied in many laboratories and used in a
variety of applications (2). The earliest use of phage was to control human disease but, a
poor understanding of phage biology, coupled with the discovery of antibiotics, lead to
the downfall of phage therapy (2). Instead, phage made their claim to fame, in the
laboratory, as one of the most influential research tools in history. Some of the most
significant contributions to biology can be attributed to work with phage including the
identification of DNA as the molecule of inheritance, the understanding of the genetic
code and the development of molecular biology (3, 4). Studies have demonstrated their
abundance in nature (1), the diversity of their genomes (5), their impact on the carbon
cycle (6) and their contribution to bacterial evolution (7).
Phage influence bacterial evolution by applying selective pressures to bacterial
populations both directly, by killing susceptible bacteria and leaving resistant ones to
thrive, and indirectly, by increasing bacterial fitness through the trafficking of genomic
islands (8, 9). The ability of bacteria to adapt to new conditions is most often the result of
the acquisition of new genes through horizontal gene transfer and other phage-mediated
recombination events. Phages depend on their host. Therefore, it benefits them to carry
genetic tools that can increase the fitness of their host (i.e. antibiotic resistance cassettes,
toxin gene) (10). Bacteria fight back by evolving defense mechanisms. Conceivably, the
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evolutionary arms race between phage and bacteria has been underway since life began
making bacteriophages a potentially rich resource for the discovery of candidate
antibacterial agents.
Phage protect the delicate balance of our ecosystem by mediating critical
ecological processes (i.e. nutrient cycling, decomposition) by controlling bacterial
populations (6). Phage also pose a risk to human health by contributing to the success of
bacterial pathogens. The signs and symptoms of many serious bacterial diseases are due
to toxins which are encoded by bacteriophage (Cholera, Scarlet fever, Diphtheria) (11).
Phage are useful in the fight against pathogens because they have evolved and continue to
evolve mechanisms to overcome the defenses of bacteria. Phage constitute one of the
most expansive collections of novel genes and gene products. These genes and gene
products have been honed by billions of years of evolutionary competition with bacteria
to be the perfect weapons against bacteria (12).
Recently, phage research has focused on genomics and the understanding of
genetic regulatory mechanisms. The development of the “informed” tools that are needed
to make an enduring impact in microbial control may benefit from the study of the
mechanisms that control gene expression (13). Understanding when and how phage use
their own genetic tools will improve our understanding of their utility in human
applications.
Phage Morphology
Compared to animal or plant viruses, phages have a complex morphology. They
have a capsid, or head, which encloses their genetic material and many also have tails.
The genomes of most bacteriophage are double stranded DNA (dsDNA). However, other
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nucleic acid and strand configurations are possible (i.e. ssDNA, dsRNA and ssRNA).
Phages have compact genomes that are expressed in a highly regulated manner. Thus,
bacteriophages provide excellent models for understanding mechanisms of controlling
gene expression. Temperate phages have been a rich source of information because they
are capable of switching between two lifestyles: lytic and lysogenic.
Lytic vs Lysogenic lifestyles
The lytic cycle is characterized by the lysis of the host cell and release of new
phage particles at the end of the infection process (Figure 1). Phage infect specific hosts
by binding to receptors on the host’s surface. The DNA in the head of the phage is
ejected through the tail and into the cytoplasm of the host. Once in the cytoplasm, the
genome circularizes and the host transcription machinery begins transcribing early phage
genes. DNA replication proteins are made and many copies of the phage genome are
generated. Structural components, such as head and tail proteins, are mass produced. The
new phage particles self-assemble and the genome is packaged. At the end of the cycle,
enzymes encoded by the phage degrade the host’s cell wall promoting cell lysis and
phage release. Phage committed exclusively to this pathway are termed lytic phage (14).
The alternative lifestyle adopted by temperate phages is called lysogeny (Figure
1). The entire phage genome physically integrates into the host’s chromosome. The
integration of the phage takes place at a special attachment site in the host genome. The
sequence of the bacterial attachment site is called attB and the sequence in the
circularized phage genome is called attP (Figure 2). An incorporated phage genome is
referred to as a prophage and it is copied along with the host chromosome each time the
host cell replicates. Thus, the prophage is a heritable part of all daughter cells without
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cycling through the entire infection process. The host cell and all its descendants are said
to be lysogenic for the infecting phage and the host cell harboring a prophage is called a
lysogen. A phage-encoded repressor protein maintains this dormant state by silencing the
expression of all phage genes except for its own. Spontaneous derepression can cause the
phage to excise itself and enter the lytic cycle. More often, the prophage is induced to
enter the lytic cycle in response to DNA damage in the host, (14).
Two factors, integrase (Int) and excisase (Xis), mediate integration and excision
of the phage genome. The genes which code for integrase (int) and excisase (xis) are
among the last to be expressed in the left operon. The Int protein is expressed from its
own promoter, PI, which is activated only during a lysogeny event. Though integration
and excision are complex processes, it is important to note that high levels of Int favor
integration while equal concentrations of Int and Xis favor excision (14).
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Figure 1. The lytic and lysogenic lifestyles. The phage genomic DNA is colored red. The
bacterial (host) chromosome is colored blue.
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A paradigm for gene regulation: Phage λ
Phage λ is the best-characterized temperate phage. It was discovered in 1951 by
Esther Lederberg while she was investigating phenotypic differences between two strains
of Escherichia coli, one of which had been mutagenized with UV light (15). Dr.
Lederberg observed a “nibbled on” appearance of the bacterial colonies, which was
evidence of cell destruction. It was concluded that the UV light had induced a prophage
to enter the lytic cycle (15). Lambda is one of the first viruses to be understood at the
molecular level and its study has led to the development of multiple tools and techniques
used in molecular genetics. Lambda is used as a cloning vector and as a gene delivery
system (16, 17). It has been a very informative model for the molecular basis of genetic
recombination (18, 19). Studies on λ led to the discovery of restriction enzymes and,
eventually, to their use in genetic engineering (20, 21). More recently, studies on λ have
led to the development of genome engineering techniques that use phage-encoded DNA
recombination enzymes. One such technique, called Recombineering, is based on the
λRed system (22). The tools for molecular genetics and the knowledge associated with
their use have grown in tandem with the understanding of λ biology.
Lambda and its relatives specifically infect Escherichia coli cells and they all
have a characteristic gene organization. The early genes of lambdoid phages are
organized into two divergently transcribed operons (Figure 2). The right operon carries
genes necessary for genome replication, late gene regulation (the Q antitermination
protein), phage morphogenesis and host cell lysis. The left operon carries the early gene
regulator (the N antitermination protein), as well as the DNA replication and
recombination proteins. The expression of all phage genes is tightly regulated.
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Figure 2. The bacteriophage λ genome. The λ genome is represented in its circularized
form. The arrows indicate the direction of transcription
n from the major promoters. The
dashed lines represent operons. The blue (left operon) and red (right operon) arrows show
early genes that are regula
regulated by the N protein. The green arrow shows late genes that
are regulated by the Q protein. The attP site is labeled within the circle.
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Transcription elongation and control
Transcription is the first step in gene expression. As with all viruses, phages rely
on the transcription machinery of their host. During transcription of most bacteriophages,
DNA serves as a template for the production of messenger RNA (mRNA). The
“message” is subsequently translated into a sequence of amino acids that ultimately folds
into a biologically active protein. Transcription occurs in three stages: initiation,
elongation and termination (14). Initiation occurs at specific DNA sequences called
promoters. Promoters are located at the beginning of genes and are responsible for
directing RNA polymerase (RNAP) to begin the process of synthesizing RNA. Hostencoded bacterial transcription initiation proteins, known as sigma factors, enable RNAP
to specifically bind to a promoter (23). Elongation refers to the growing strand of mRNA
created by RNAP after each successive nucleotide addition. RNAP continues to copy the
DNA for long distances until its progress is interrupted by transcription terminators
which cause the transcription complex to dissociate.
In bacteria, transcription termination signals are grouped into two classes:
intrinsic and factor-dependent terminators (24, 25). Intrinsic terminators are composed of
a GC-rich RNA hairpin followed by a run of U residues. Termination at an intrinsic
terminator occurs in two steps. First, RNAP pauses within the U track and then the
interaction between the hairpin and RNAP causes the RNA to be released. No protein
factors are required for this to occur, however, certain accessory proteins such as NusA
can enhance recognition of intrinsic termination signals by the elongation complex (26).
Intrinsic termination signals are common in E. coli and their characteristic features can
easily be identified by computational analysis.
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In contrast to intrinsic terminators, factor-dependent terminators rely on the
interaction of regulatory proteins. One such factor is Rho, found in many prokaryotes.
Rho is an ATP-dependent translocase. It recognizes and binds to a specific sequence in
mRNA called the Rho utilization site or rut and uses the energy of ATP hydrolysis to
move along the transcript in a 3’ direction until it encounters RNAP (27). Rho can then
stop transcription by using its helicase activity to unwind the RNA-DNA hybrid (28, 29).
Regulatory mechanisms have been identified at virtually every stage of
transcription, including termination (30). In fact, some viruses have evolved the ability to
override transcription termination signals. This mechanism is known as antitermination
(24). Transcription antiterminators modify RNAP and convert it into a terminator
resistant form. This allows the expression of genes downstream of terminator sites.
Transcription terminators are located throughout lambdoid phage genomes and
antitermination is necessary for the full expression of phage genes (31). Persistent
antitermination, defined as readthrough of multiple sequential termination signals, was
originally discovered in phage λ (32). In λ, the transition between the expression of early
genes to those required at later stages of infection depends on the readthrough of
termination signals. Antitermination of the λ early genes is mediated by a phage-encoded
factor called N (33). The late genes are antiterminated by a different antiterminator, the Q
protein. The Q protein, acting through a different mechanism, converts RNAP into a
termination resistant form and promotes the readthrough of termination signals in the late
gene operon.

9

Antitermination of early gene transcripts in phage λ
To suppress termination of early gene transcription originating from the early
gene promoters, PL and PR, the N protein binds as a dimer to a stem-loop structure in the
nascent nut RNA transcripts (34). There is a copy of the nut site in each operon.
The association of N and RNAP is stabilized by a network of weak protein-protein and
protein-RNA interactions. The host-encoded Nus factors, NusA, B, E and G, assemble to
form an elongation complex (31). The name “Nus” stands for N-utilization substance
(35). Through RNA looping, the N-nut complex binds RNAP through the NusA adapter
protein (Figure 3) (34). NusG also interacts directly with RNAP to stablize the elongation
complex (36).
The RNAP-N-Nus complex, once assembled, is resistant to sequential
downstream termination signals. This type of persistent antitermination is said to be
factor-dependent because readthrough of termination signals depends on the action of a
protein factor (37). The N antiterminator protein is the first gene to be expressed in the
left operon of λ. The nutL sequence is located between the N gene and the promoter. In
the right operon, nutR is located immediately downstream of cro thus making the
expression of N, in the left operon, necessary for antitermination to occur in the right
operon.
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Figure 3. Current model of N -mediated antitermination. This simplified
plified diagram shows
the interaction between RNA polymeras
polymerasee (purple), the N protein dimer (blue ovals), and
the host-encoded factors that convert RNA polymerase into
to a terminator resistant form
during transcription (gray ovals)
ovals). Transcription begins at the promoter, labeled “P,” and
continues through the nut site (blue) and N gene (white box). The nut sequence embedded
within the mRNA transcript folds into the stem-loop
loop structure (orange). Once assembled,
the complex is stable and terminator resistant. The stop sign represents a transcription
terminator. Adapted (31)..
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The antiterminator RNAs of bacteriophage HK022
Bacteriophage HK022 is a member of the lambdoid family and also uses
processive antitermination to regulate the expression of its early genes. However, it does
not produce an analog of the λ N protein (38, 39). In contrast to phage λ, antitermination
in HK022 is factor-independent. Terminator readthrough is promoted by the direct
interaction of the nascent RNA transcript with RNAP (40, 41). The transcripts of the put
(polymerization utilization) sites fold into a highly organized, dual stem-loop structure
that converts RNAP into a terminator resistant form (Figure 4) (39, 40). A put site is
located in each early operon of HK022. Mutations that occur in the zinc binding domain
of the β’ subunit of RNAP block the interaction between put and RNA polymerase and
prevent the growth of HK022 (42). One such mutant, rpoCY75N, has been useful in
identifying additional bacteriophage that use antiterminator RNAs (43). RNA-mediated
transcription antitermination challenges the protein mediated mechanism found in the
well-established λ paradigm (40).
The put RNA transcripts are a unique example of a regulatory RNA.
Traditionally, RNA has been thought to only participate in post-transcriptional gene
expression events such as protein synthesis. During protein synthesis, messenger RNA
(mRNA) serves as a template for the assembly of proteins on ribosomes. Transfer RNAs
(tRNA) transport amino acids to the ribosome where ribosomal RNAs (rRNA) catalyze
peptide bond formation to link amino acids together to form proteins. While the role of
RNA in translation is well established, RNA is now known to play other critical roles in
the cell (44, 45). Research efforts are now actively being focused on understanding the
roles RNAs play in controlling gene expression (46, 47). A large number of
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riboregulators have been identified. Of these, microRNAs (miRNAs) and small
interfering RNAs (siRNAs) are the best characterized. miRNAs are short sequences of
RNA that function as gene silencers by binding to mRNA transcripts through
complementary base pairing and blocking the progress of translating ribosomes (47). This
interference results in the premature degradation of the transcript. The siRNAs have a
similar function. The distinction between the two small RNA molecules derives from
their ability to silence their own expression. Most siRNAs silence the loci from which
they were transcribed while miRNAs silence genes from other loci (48).
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Figure 4. Current model of put-mediated antitermination. Antitermination in HK022 is
mediated by an interaction between the nascent mRNA transcript and RNA polymerase.
RNA polymerase initiates transcription at the promoter (black arrow). The put site (blue)
is transcribed and the mRNA folds into a stem
stem-loop structure (orange).. The nascent
transcript interacts with the β’ subunit of RNAP and converts the
he enzyme into a
terminator resistant form allowing read
read-through
through downstream terminators (stop
(
sign).
Adapted (49).
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The antitermination mechanism of bacteriophage HK639
Bacteriophage HK639 was discovered because it cannot grow on the rpoCY75N
mutant. This mutation blocks the interaction between RNAP and the put transcript (42).
This result suggested that it may also use RNA-mediated antitermination. It is a
temperate phage and its genome has been completely sequenced (43). Overall, its genetic
organization broadly resembles phage λ and other members of the lambdoid family
(Figure5). A closer look, however, reveals intriguing differences in regards to its
regulation of early gene expression. A put-like sequence in the left operon of HK639 was
identified and it was shown that this site promotes antitermination by interacting with
RNA polymerase in a manner similar to the HK022 put sites (43)

15

Figure 5. Maps of lambdoid
ambdoid phage early genes. Transcription of the early genes begins at
the promoters, PL and PR (black arrows). Genes and key regulatory sequences are
indicated with boxes. Those known to be involved with antitermination are shaded blue.
Transcription terminator(s)
erminator(s) are represented with stop signs.
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Unlike the left operon, a put-like sequence could not be identified in the right
operon of HK639 using BLAST (43). To determine if a structural homolog of put was
present in the right operon, the RNA folding program, Mfold (50), was used to fold
untranslated regions of the right operon transcript (43). No structures analogous to the
HK022 putL or putR sites were identified (43). In addition, there are no sequences that
have statistically significant similarity to known nut sites or to known N-like proteins.
To determine if HK639 right operon transcription is antiterminated by factorindependent RNA-mediated antitermination, a segment of the early right operon
sequence which included cro, cII, and the intergenic regions between cII and the initial
portion of orf38 was fused upstream of Tr’T1T2 in a reporter construct (43). Similar
fusions were made without the terminator set. Reporter assays revealed no readthrough of
the terminator cluster. It was concluded that no put-like antiterminator RNA was present
in the selected early region of the HK639 genome (43).
The lack of an antiterminator in the right operon of HK639 was unexpected. It
was hypothesized that perhaps antitermination is not necessary for the expression of right
operon genes. However, a computer aided search revealed a single Rho-independent
terminator in the early right operon. The presence of this terminator suggests that it must
be suppressed so that downstream genes can be fully expressed. Rho-dependent
terminators are difficult to identify by computer analysis. Consequently, no information
is available on the presence and/or location of Rho-dependent terminators in the HK639
genome (43).
To test for the presence of an antitermination mechanism in the right operon,
recombineering was used to insert a set of 3 strong terminators at different locations in an
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HK639 prophage (Tr’T1T2-glyT-kan) fusion (Figure 6) (43). Controls were constructed
by recombining a fusion without terminators (glyT-kan) into the same genomic locations.
Fusions with or without terminators made in or near the M3 region were unable to release
phage. This result suggests that an essential function was disrupted by these fusions. The
function of the M3 region is currently unknown. Two fusions that were made further
downstream of M3 were able to release phage (43). These results suggest that
antitermination does occur in the right operon of HK639. (43).
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Figure 6. Map of terminator fusions in right operon of HK639. The boxes
es indicate the
approximate locations at which fusions were made
made.. Red indicates fusions that were
unable to release phage. G
Green indicates fusions which were able to release phage.
Terminators are labeled
eled with red arrows.
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The goal of my research was to better understand early gene expression of
lambdoid phage by comparing and contrasting the newly discovered bacteriophage
HK639 with the mechanisms characterized in bacteriophages λ and HK022. Phage
HK639 does not appear to have any of the known antitermination elements in its right
operon. However, our evidence suggests that antitermination does occur in both early
operons. To determine if host-encoded factors essential for protein-mediated
antitermination are required for antitermination in HK639, host strains carrying precise
deletions of the nusA or nusG genes, were infected with HK639 and the growth of the
phage on each mutant was compared to the growth on wild-type strains.
In HK022, there are no genes in the left operon that are required for lytic growth.
To determine if the same is true for HK639, we deleted the left operon promoter and putL
antitermination sequences from an HK639 prophage. Additional replacements of left
operon sequences suggest that antitermination is not the only requirement for phage
growth. It was expected that these studies would provide insight into how HK639
controls the expression of its early genes. Additionally, it was expected that this work
would reveal valuable information regarding the biology of this newly discovered
bacteriophage.
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MATERIALS & METHODS
Bacterial strains, plasmids and bacteriophages
Bacterial strains, plasmids and bacteriophages used in this study are listed in
Table 1.
Media
The recipes for bacteriological media used in this study are as follows: Luria
Bertani (LB) broth (per liter): 10 g Tryptone, 5 g yeast extract, 5 g NaCl. Typtone (TB)
broth (per liter): 10 g Tryptone, 5 g NaCl, pH to 7.4. LB plates (per liter): 10 g Tryptone,
5 g yeast extract, 5 g NaCl, 15 g agar. TB top agar (per liter): 10 g Tryptone, 5 g NaCl, 7
g agar, pH to 7.0. SOC (per liter): 20 g Tryptone, 5 g yeast extract, 0.5 g NaCl, 1.25 ml of
2M KCl, 5 ml 1M MgCl2, 1 ml 1M MgSO4, 2 ml 1M glucose. TMG (per liter): 10 ml 1M
Tris base, 10 ml 1M MgSO4, 100 mg gelatin, adjusted to pH 7.4 with HCl. 50X TAE
(per liter): 242 g Tris base, 57.1 ml glacial acetic acid, 100 ml 0.5M EDTA.
Overnight cultures
Cells were grown in 5 ml overnight culture at 37°C in TB or LB broth with
shaking at 220 rpm unless otherwise noted. Antibiotics were added (when required) at the
following concentrations: ampicillin (100 µg/ml; 25 µg/ml for screening recombineering
candidates), kanamycin (20 µg/ml). Following overnight incubation, cells were harvested
by centrifuging at 2,750 x g for 10 minutes. The resulting cell pellet was suspended in
half the volume of 10 mM MgSO4 and stored at 4°C.
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Table 1. Bacterial strains, plasmids and bacteriophage
Strains

Relevant genotype or characteristics

Reference

MC1000

∆(lac)X74

51

RK1097

MG1655(HK022 @ tRNAgly at 10Kb)
rpoC+/pLUXam; SB1424/pSB1326; ampR, camR,
kanR

52

RK1145

MC1000 (HK639) transformed with pRK1006; ampR

King, R.

RK1275

RSW414 = MDS42 tonA- reduced genome

53

RK1276

RSW421 = MDS42 ∆nusA::camR

53

RK1277

RSW422 = MDS42 ∆nusG::kanR

53

RK1278

RSW472 = MG1655 ∆rac::camR

53

RK1279

RSW481 =MG1655 ∆rac::camR; ∆nusG::kanR

53

RK1288

RK1145 ∆PL-putL::kanR

This work

RK1319

RK1145 ∆putL::kanR

This work

RK1321

MC1000; pBR322/PL-putL::kanR

This work

RK1328

RK1145 ∆30,888-33,048::kanR

This work

RK1329

RK1145 ∆29,152-30,887::kanR

This work

RK1330

RK1145 ∆27,406-29,151::kanR

This work

RK1331

MC1000; pBR322/putL::kanR

This work

RK1332

RK1145 ∆26,022-27,406-::kanR

This work

RK898

RW4198 = MG1655; wild-type, rpoC+

Weisberg, R. unpublished

RK899

RW4200 = MG1655; rpoCY75N

Weisberg, R. unpublished

pBR322

Cloning vector in E. coli; ampR, tetR

NEB Cat. No. N3033S

pRK1006

pSim6 [= ori-pSC101repA(ts) (cI857 PL-exo-bet-gam;
ampR)]
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pRK1321

pBR322 with PL-putL::kanR

This work

pRK1331

pBR322 with putL::kanR

This work

Plasmids

Phage
HK639

54

22

Microfiltration
Microfiltration was performed using Amicon Ultra 0.5 Centrifugal Filter Devices
(Fisher Cat. No. UFC510096). Sterile npH2O, 500 µl minus the sample volume, was
pipetted into the filtration device. Nanopure water (npH2O) is high purity deionized water
made from a Barnstead Nanopure Infinity Ultrapure water system. The sample was added
to the water and mixed well. To remove salts, the sample, was centrifuged at 10,000 x g
for 10 minutes at room temperature. The sample was washed 3X by adding 500µl of
sterile npH2O and centrifuging at the settings previously described. The flowthrough
volume was discarded after each centrifugation. The purified sample was collected by
inverting the filtration device and centrifuging at 1,000 x g for 2 minutes. The typical
volume recovered was ~20 µl.
Polymerase Chain Reaction
Taq polymerase (Fisher Cat. No. FB-6000-15) was used to amplify products of
less than 1000 bp. The thermocycler settings for reactions in which Taq polymerase was
used were as follows: 95°C for 1 min, 34 cycles of 95°C for 1 min, 55°C for 1 min, 72°C
for 2min, then 72°C for 10 min followed by a 4°C hold.
Phusion High Fidelity PCR Kit (NEB Cat. No. E0553L) contains a high fidelity
polymerase that creates products with blunted ends and has an error rate that is estimated
to be >50 fold lower than that of Taq polymerase. This enzyme was used where high
fidelity was required (i.e. amplification of the kanamycin resistance gene). The
thermocycler settings were as follows: 98°C for 30s, 34 cycles of 98°C for 10s, 52°C for
30s, 72°C for 2 min, then 72°C for 10 min followed by a 4°C hold. A list of
oligonucleotides used in this work can be found in Table 2 and Table 3.
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Table 2. Oligonucleotides used for PCR
Name

Sequence

Use/Special Features

RK192 CTCGAAACGAATAGCATTTAC

RK290 TTGCCATGTTTCAGAAACAACTC

To confirm upstream junction, strain
RK1332
To confirm downstream junction, strain
RK1319
To confirm upstream junction, strain
RK1288
To confirm upstream junction, strain
RK1319
Primes within kanR, forward

RK291 GATCTTGCCATCCTATGGAAC

Primes within kanR, reverse

RK299 CACGCTTCAGCCTTCAGCTTGT

RK710 TCACGGATCCGTTTTTTTATCTGC
CATACAC

To confirm downstream junction, strain
RK1330
To confirm upstream junction, strain
RK1328
To confirm downstream junction, strain
RK1288
To amplify kanR from RK1288 & RK1319;
BamHI site is underlined

RK711 TCAGAAGCTTTGTGAGCATAGCA
CTCATG

To amplify kanR from RK1288; HindIII site
is underlined

RK734 CTCTGCAAGACGCTTGCTTTC

To confirm downstream junction, strain
RK1328
To confirm downstream junction, strain
RK1329
To confirm upstream junction, strain
RK1329
To confirm upstream junction, strain
RK1330
To amplify kanR from RK1319; HindIII site
is underlined

RK227 TCAGGAATTCCCTGAAAGGAAC
RK232 GGAATTTCTCTTCCAATGAAC
RK277 CTGTTTTTGTGAGCATAGCAC

RK570 CGCGGCAAGCCAAAATATAG
RK659 CCCGATGATTTTGACTTTGAG

RK735 GCGAAGTACTGCCTCTTTCC
RK736 CCATCCAGTCACTATGTGAGG
RK737 GGTTCGCCACCGTCTTGAGTTG
RK738 TCAGAAGCTTTAATCCATCGAAA
CGAAACATC
RK742 GATGTGTCATGCATTAATGAGC

To confirm downstream junction, strain
RK1332
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DNA gel electrophoresis
Gel electrophoresis was performed using Fisher brand electrophoresis systems
(Fisher Cat. No. FB-SB-710 or FB-SB R-1316). Two percent agarose gels were used to
identify DNA molecules that were less than 1000 bp in length and 1.3% gels were used to
identify bands greater than 1000 bp in length. DNA size standards used included 100 bp
ladder (Axygen Cat.No. M-DNA-100BP), 1Kb ladder (Fisher Cat. No. BP2578100), 2
Kb ladder (Fisher Cat. No. BP2578100) and λ DNA /Hind III (Fisher Cat. No. PRG1711). Gels were run in 1XTAE buffer. The voltage settings are 10 v/cm for 60 minutes
(FB-SB-7100 and 6 v/cm for 90 minutes (FB-SB R-1316).
Restriction digests
Restriction enzymes used in this study include: BamHI (NEB Cat. No. R0104S)
and HindIII (NEB Cat. No. R0136S). A typical digestion reaction contained 20 µl of
DNA, 2 µl of restriction enzyme, (BamHI digestions were supplemented with BSA to
final concentration of 1X), 5 µl of appropriate 10X buffer, and npH2O to 50 µl total
volume. Restriction digest reactions were incubated at the recommended time and
temperature. For sequential digestions, HindIII (a heat labile enzyme) was heat
inactivated by incubating at 65°C for 20 minutes. Buffer exchanges, when necessary,
were performed using microfiltration as previously described.
Extractions of DNA fragments from agarose gels
For purifying desired DNA fragments, 2 µl of loading dye per 5 µl of restriction
digest was added to the restriction digest sample. The sample was divided into 10 equal
volumes and distributed evenly among the wells of an agarose gel (12 µl/well). Gels were
stained for at least 10 minutes in 1X TAE buffer that contained 0.5 µg/ml ethidium
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bromide. To visualize the DNA fragments, the gel was placed on a UV light table and the
desired region was removed from the gel with a razor blade. The agarose strip was
divided into equal halves and placed into sterile microfuge tubes where it was sliced into
smaller fragments using an 18 gauge needle. The DNA was extracted from the gel matrix
using the phenol-freeze method (55). The samples were vortexed then frozen at -80°C for
15 minutes. Frozen samples were then centrifuged and the aqueous solution was
extracted using a pipette. This solution was separated into equal volumes. To remove all
traces of phenol, twice the volume of chloroform was added to each tube. After briefly
vortexing the samples, they were centrifuged to separate the aqueous and organic layers.
The aqueous layer was removed and chloroform extraction was repeated once. The DNA
was recovered from the aqueous layer using ethanol precipitation.
Ethanol precipitation
Following gel extraction, a 1/10 volume of sterile 3M Na(C2H3O2)2 , pH 5.2 was
added to samples containing DNA followed by 2X the volume of 100% cold ethanol.
Samples were chilled at -20°C for 20 minutes and then centrifuged at 17,200 x g for 25
minutes at 4ºC. The supernatant was decanted and the pellets containing the DNA were
allowed to air dry by inverting the microfuge tubes on a paper towel. In cases where the
same DNA sample had been distributed among multiple tubes, one of the DNA pellets
was suspended in 50 µl of elution buffer (10 mM Tris-Cl, pH 8.5) and this solution was
then transferred to the other sample tubes until all the DNA pellets were dissolved in the
same volume of buffer. In lieu of a wash with 70% ethanol, these samples were purified
using microfiltration as described above.
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Ligations
Ligations were performed using T4 Ligase (NEB Catalog No. M0202S). A typical
ligation reaction consisted of insert, vector, 2 µl of ligase buffer, 1µl of ligase and npH2O
to 20 µl total volume. The volume of insert and vector were determined on a case by case
basis depending upon their concentrations as visualized by gel electrophoresis. An
attempt was made to include approximately twice the amount of insert as vector. A no
insert control was included with each ligation reaction. Ligation reactions were incubated
overnight at 14°C. The next day, the T4 Ligase was heat inactivated by incubating the
reaction at 65°C for 20 minutes.
Preparation of electrocompetent cells
Overnight cultures were diluted 1:100 in LB broth in two separate 5ml aliquots
and grown at 37ºC with shaking at 220 rpm. At an O.D.650 of 0.4, the cultures were
centrifuged at 2,750 x g for 10 minutes at 4ºC. The supernatant was discarded and the
pellet was resuspended in ice cold 10% glycerol using a serological pipette. The cells
were pelleted by centrifugation. The cells were subjected to two additional washes with
ice cold 10% glycerol. After the third wash, the pelleted cells were resuspended in 1.5 ml
of ice cold 10% glycerol transferred to a cold microcentrifuge tube and centrifuged at
3,500 x g for 10 minutes. The supernatant was decanted and the pellet was resuspended
in the volume of supernatant remaining in the tube (~50 µl). The electrocompetent cells
were always used immediately.
For preparing electrocompetent cells for recombineering experiments, overnight
cultures of the recombineering strain, RK1145, were diluted 1:100 in LB broth
supplemented with ampicillin (20 µg/ml) in two separate 25 ml aliquots and grown at
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30ºC with shaking at 220 rpm. At an O.D.650 of 0.3 to 0.4 one flask was put in a 42ºC
water bath, and incubated, for 15 minutes with shaking at 220 rpm. Incubation of the
other flask was continued at 30ºC; this culture served as the uninduced control. Next,
both flasks were rapidly chilled in an ice water bath and were kept cold for the remainder
of the procedure. Samples from each culture (12.5 ml) were transferred to two 15 ml prechilled conical tubes. From this point on, cultures were treated as outlined above.
Electroporation
All DNA samples and electrocompetent cells were kept on ice throughout this
procedure. DNA was added to 50 µl of freshly prepared electrocompetent cells at
100 ng/µl (not to exceed 10 µl in total volume) or 2 µl of plasmid prep. Cells were
transferred by pipette to pre-chilled 2 mm electroporation cuvettes (Fisher Cat. No.
FB102). Electroporation was performed using the Bio-Rad Gene Pulser xCell at 2.5 kV,
25 µf, 200ohm. Time constants were typically 5.1 milliseconds. For plasmid
electroporations, the cells were resuspended in 1ml of SOC and transferred to 15 ml
cultures tubes. The electroporated cells were incubated at 37°C with shaking at 220 rpm
for 1 hr. Cells (100 µl) were plated on LB supplemented with kanamycin (20 µg/ml) and
incubated at 37°. The next day, transformants were streaked for isolation on LB plates
supplemented with kanamycin (20 µg/ml). After obtaining purified colonies, overnight
cultures were prepared and processed as outlined above. Cultures were suspended in 10
mM MgSO4 and stored at 4ºC for further testing. For recombineering electroporations,
the cells were treated as described below (see “Recombineering”)
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Plasmid isolation
Cells were grown in 5 ml overnight culture in LB broth supplemented with the
appropriate antibiotic. Cells were harvested by centrifuging at 2,750 x g for 10 minutes at
4ºC. Plasmid isolations were performed using the QIAprep Spin Miniprep Kit (Qiagen,
Catalog No. 27104) or QIAfilter Plasmid Purification Midi Kit (Qiagen, Catalog No.
12243) according to the instructions provided by the manufacturer.
Plaque assays
To determine the titer of HK639 on ∆nus mutants a serial dilution (10-0 -10-9) of
phage lysate was prepared in TMG buffer. A 10µl aliquot of each dilution was added to
50 µl of an overnight culture of susceptible host cells in 5 ml culture tubes (Fisher Cat.
No. 14-959-11A). The mixture was incubated at room temperature for 20 minutes to
allow time for phage attachment to occur. Four milliliters of molten (55 °C) TB top agar
supplemented with MgSO4 at10 mM final concentration was added to the cell/phage
mixture. The culture tubes were mixed by inversion and the solution was poured over
pre-warmed LB plates. After the top agar had solidified, the plates were inverted and
incubated overnight at 37°C. The following day, titers were determined by counting the
plaques; a plaque is a clear zone on a plate otherwise covered with an opaque lawn of
bacterial cells. To calculate the titer, the dilution which showed 30-300 individual
plaques was identified. The plaque forming units, or PFU, was divided by the volume of
sample plated and then multiplied by the reciprocal of the dilution to obtain the titer in
PFU/mL.
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Recombineering
Strain RK1145 was grown in a 5ml overnight culture at 30°C in TB broth
supplemented with ampicillin (20 µg/ml). Following overnight incubation,
electrocompetent cells were prepared as outlined above. The recombineering substrate (a
PCR amplified DNA), was added at 100 ng. No DNA was added to the control culture.
The DNA and cell mixtures were added to pre-chilled 2mm electroporation cuvettes.
Cells were electroporated as outlined above. The cells were resuspended in 1ml of SOC
and transferred to 15 ml cultures tubes. The electroporated cells were incubated at 30°C
with shaking at 220 rpm for 2 hrs. Cells were concentrated by centrifugation and
resuspended in 300 µl of LB broth. Cells (100 µl) were plated on LB broth supplemented
with kanamycin (20 µg/ml) and incubated at 30°C. The next day, transformants were
streaked for isolation on LB plates supplemented with kanamycin (20 µg/ml). After
obtaining purified colonies, overnight cultures were prepared and processed as outlined
above. Cultures were suspended in 10 mM MgSO4 and stored at 4ºC for further testing. A
list of recombineering oligonucleotides is provided in Table 3.
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Table 3. Recombineering oligonucleotides list
Name

Sequence

RK654 GAGCATAGCACTCATGATTTACAAAAATAAATTCATTTAGTTATCAT
TAATTTATAACTTATGTGATTGtccgacaaccgatgaaagc
RK655 GTTTTTTTATCTGCCATACACACCCCTCTGTTTGTTTACCGTCAGCCC
CTCGCAAAGAGCTGCTGGTAAATCGgtggaccagttggtga
RK706 ATAGCTGAGGGAAGTTAGCCAGCGGCGAAGTGGAGATTCGGTCAGT
CGAAtccgacaaccgatgaaagc
RK707 TGTTTGTTTACCGTCAGCCCCTCGCAAAGAGCTGCTGGTAAATCGTT
TAGgtggaccagttggtgattttg
RK726 TACGCGCGGCCACACCCGACGGCCCGCAGTTTTATAAAACAATGTCA
TAGtccgacaaccgatgaaagc
RK727 TAGGTCGTAGGTTCGAATCCTACAGGGCGTGCCATTTAAAAACAGTC
GCTgtggaccagttggtgattttg
RK728 AAGCGCAGAAGTCTTGTTTAACGTTCGGCGGCGCGGCCTTAAGCGCG
GAGtccgacaaccgatgaaagc
RK729 GAATCAGTCAGCTTTGCGAAATCATTGGCGATCTGGTAAAGAGCTGT
CATgtggaccagttggtgattttg
RK730 AGGCCGTCTATGCCAAGTGCAAAGCAAAATTCGAAGAGGTTACGCA
ATGAtccgacaaccgatgaaagc
RK731 AAACGCCAGCAAATGCAGGGGCCGCATTAGCGACCCGGTGATTTGT
GCTGgtggaccagttggtgattttg
RK732 AGTTGCTGCCAGGATGCGCGATCGACGTGATCAAAACGGAGGCCGC
ATGAtccgacaaccgatgaaagc
RK733 TTTCGCTGCCTTTTGCGCAGTGAGTGGCTCTGCTGTAACCATCTCCCC
TCgtggaccagttggtgattttg
Sequences in lowercase represent regions with homology to the kanamycin resistance
gene located in strain RK1097. Sequences in uppercase represent regions with homology
to the target region.
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Sequencing
Sequencing reactions were prepared using the BigDye Terminator v3.1 Cycle
Sequencing Kit (ABI, Catalog No. 4337457). Each reaction contained 2 µl sequencing
juice, 2 µl BigDye Terminator buffer, 1 µl primer, at least 50 ng of DNA (up to 5 µl) and
npH2O to 10 µl total volume. The thermocycler settings were as follows: 25 cycles of
96°C for 30s, 50°C for 15s, 60°C for 4 minutes followed by a 10°C hold. Reactions were
cleaned-up using SigmaSpin Sequencing Reaction Clean-Up kit (Sigma Catalog No.
S5059). The samples were dried using a centrivap and the pellets were suspended in 20 µl
of formamide. Sequences were run on an ABI 3130 sequencer.
Phage release assays
To determine the effects of mutations on phage viability, lysogenic strains made
in this study (Table 2) were tested for spontaneous and induced phage release. One
milliliter of overnight culture, grown in TB broth supplemented with kanamycin (20
µg/ml), was transferred to each of two sterile microfuge tubes. One tube of culture was
treated with 100 µl of chloroform while the other tube was left untreated. After vortexing,
the cells were pelleted and the lysate was transferred to a sterile microfuge tube. The
lysates (5 µl) from lysogenic strains were spotted onto a lawn of susceptible host cells
(MC1000). These lawns were prepared by adding 50 µl of an overnight culture of host
cells, to 4 ml of molten TB top agar in 5ml culture tubes (Fisher Cat. No14-959-11A).
After inverting to mix, the solution was poured onto a pre-warmed LB plate and allowed
to solidify. Plates were inverted and incubated overnight at 37°C.
To determine if the lysogenic strains were capable of releasing phage particles
after induction, 250 µl of overnight culture was inoculated into 5 ml of LB broth
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supplemented with kanamycin (20 µg/ml) and grown to an O.D.650 of 0.1. Mitomycin C
was added to a final concentration of 2 µg/ml. After incubating for 5 hours, at 30°C with
shaking at 220 rpm, the mitomycin C treated cultures were processed as described above.
The mitomycin C induced lysate was then plated as described above.
Phage infection
To cross the ∆PL-putL::kanR and ∆putL:: kanR deletion onto a lytically growing
phage, strains RK1321 and RK1331 were infected with wild type HK639. Overnight
cultures of RK1321 and RK1331, were grown in TB broth supplemented with kanamycin
(20 µg/ml) and harvested as mentioned above. Fifty microliters of each culture was added
to each of five sterile microfuge tubes. Plaques of wild type HK639 grown on MC1000
were harvested from a plaque assay plate using a Pasteur pipette. Infections were
performed by adding an increasing number of plaques to each culture-containing
microfuge tube; up to four plaques. An uninfected aliquot of each culture served as a
control. Aliquots (2 ml) of LB broth supplemented with ampicillin (20 µg/ml - 10 mM
MgSO4), were placed in each of ten 15 ml conical tubes. Five of the aliquots were
supplemented with mitomycin C-(2 µg/ml final concentration). After incubating the cells
for 20 minutes at 25ºC, the entire volume of each phage + cell mixture was transferred to
the LB broth in the 15 ml culture tubes. After a 6 hour incubation at 37ºC with shaking at
220 rpm, a lysate was prepared from each sample. To lyse the cells, 100 µl of chloroform
was added to each culture. Samples were vortexed to ensure adequate mixing. One
milliliter of each sample was transferred to a sterile microfuge tube, centrifuged at 12,100
x g for 10 minutes, at room temperature. Seven hundred fifty microliters of each sample
was removed by pipette and syringe filtered through a 0.22µm filter (Fisher Cat. No. 09 -
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719G). Lysates were stored at 4ºC. The presence of recombinant phage was tested by
PCR analysis using primer set RK227 x RK291.
One plaque lysate
Plaques from phage infections of RK1321 and RK1331 lysates were picked using
a Pasteur pipette and suspended in 100 µl of TMG. Following 2 hours of incubation at
room temp, lysates were analyzed directly by PCR for the presence of recombinant phage
using primer set RK227 x RK291.
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RESULTS
Effect of host mutations on HK639 growth
Bacteriophage λ and its relatives are dependent on host-encoded factors to
promote antitermination. The importance of these functions was discovered by isolating
host mutations that prevented phage growth. HK022 uses RNA-mediated antitermination
to promote full expression of phage genes. It has an antiterminator sequence, the put site,
in each of its early operons and it does not rely on host-encoded factors for growth. A put
like sequence was identified in the early left operon of HK639 but no sequence
resembling a put site was identified in the right operon. Because of the absence of an
antiterminator RNA in the right operon, it was hypothesized that host-encoded factors
may be necessary for antitermination of HK639 right operon transcription.
To test this hypothesis, we determined the ability of HK639 to grow on cells that
carry deletions in genes known to influence transcription elongation and termination;
nusA and nusG. Plaque assays, scoring plates for plaque formation, were performed on
each of the ∆nus mutants. The plaques were counted to obtain titers, which were used to
calculate the efficiency of plating (EOP). The average EOP values of three separate trials
are reported in Table 4.
Our results show that the nusA deletion strain, RK1276, had an EOP value of
0.14. This suggests that the deletion reduced the growth of HK639 by 86% when
compared to the wild type control, RK1275. The EOP on a strain known to block HK639
growth, strain RK899 (rpoCY75N), was <10-7. When compared to the rpoCY75N
mutation, the effect of the nusA deletion is relatively minor. Since we additionally
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observed a growth defect for the strain carrying the nusA deletion, we suggest that this
defect strongly impacted the observed EOP (see Discussion).
Our results show that strains RK1277, RK1278 and strain RK1279 have EOP
values of 0.59, 1.66 and 1.07, respectively. These results suggest that the deletion of only
nusG (RK1277) reduces growth of HK639 by 49% when compared to the wild type
control, RK1275. The rac and rac+nusG deletions do not negatively affect HK639
growth. Similar to nusA mutant, the nusG mutant has a strong growth defect associated
with the deletion of only nusG and we suggest this impacted the observed EOP (See
Discussion).
Based on these results, we conclude that it is unlikely that NusA or NusG play a
primary role in the growth of bacteriophage HK639. This result suggests that a
mechanism similar to the host factor-dependent antitermination in lambda is not involved
in regulation of gene expression in HK639.
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Table 4. Efficiency of plating assays
Strain

Titers (PFU/ml)

Avg. Titer

EOP
value*

Trial 1

Trial 2

Trial 3

RK1275

1.56 X 1010

1.40 X 1010

8.40 X 109

1.27 X 1010

1.00

RK1276(∆nusA)

1.68 X 109

1.44 X 109

1.72 X 109

1.61 X 109

0.14

RK1277(∆nusG)

6.80 X 109

6.00 X 109

7.60 X 109

6.80 X 109

0.59

RK1278(∆rac)

2.48 X 1010

2.12 X 1010

3.16 X 1010

2.59 X 1010

1.66

RK1279(∆rac, ∆nusG)

1.92 X 1010

1.12 X 1010

1.00 X 1010

1.35 X 1010

1.07

RK898

2.92 X 1010

1.08 X 1010

1.44 X 1010

1.81 X 1010

1.00

RK899(rpcCY75N)

No growth

No growth

No growth

N/A

≤10-7

*EOP values are an average of three trials
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Generating deletions in the left operon of HK639 prophage
Upon deletion of the PL promoter, HK022 continues to grow lytically (56).
Antitermination sites, located in each early operon, control the expression of HK022
early genes. HK639 has an antitermination site in its left operon but it is unknown
whether the expression of the left operon is essential to its growth. A map of the left
operon of HK639 is shown in Figure 7.
To determine if genes located in the left operon of HK639 are essential to lytic
growth, recombineering was used to make systematic deletions in the left operon of an
integrated prophage; strain RK1145. The kanamycin resistance gene (kanR), amplified
from strain RK1097, was used to replace defined segments of the HK639 left operon.
Primers RK654 and RK655 were used to generate the recombineering substrate
by PCR. Recombination with this substrate resulted in the replacement of the HK639 PL
and putL sequences and the recombinants were selected for kanamycin resistance. The
resulting strain, designated RK1288(∆PL-putL::kanR), was verified using primer sets
RK659 x RK291 and RK232 x RK290 to amplify the recombinant DNA junctions
(Figure 8). These PCR products were sequenced to confirm that each junction was
generated as designed.
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Figure 7. Map of HK639 left operon. The left operon promoter, PL, is indicated with a
black arrow. The putL
L antitermination sequence is labeled in blue. Predicted intrinsic
transcription terminators are identified with red arrows
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Figure 8. Creating the PL--putL
L deletion in an HK639 prophage. A) Generation of the
recombineering substrate. Lane 1 - 2Kb ladder. Lane 2 – recombineering substrate
amplified with primer set RK654 x RK655. The expecte
expected
d product is 1.3Kb. B)
Verification of the recombination junctions. Lane 1 - 2Kb ladder. Lane 2 – downstream
junction, amplified with primer set RK659 x RK 291
291; expected size = 600bp. Lane 3 –
upstream junction,
unction, amplified with primer set RK232 x RK290
RK290; expected size = 900bp. C)
Map of strain RK1288(∆PL-putL::kanR). The recombineering substrate included kanR
(green arrow). Primers used for recombineering and junction verification are marked with
tan arrows.. Predicted intrinsic transcription terminators are identified with red arrows.
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To replace the putL sequence only, Primers RK706 and RK707 were used to
generate a recombineering substrate by PCR. The resulting strain, designated
RK1319(∆putL::kanR), was verified using primer sets RK227 x RK291 and RK277 x
RK290 to amplify the recombinant DNA junctions. These PCR products were sequenced
to confirm that each junction was generated as designed. The results of this analysis are
shown in Figure 9.
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Figure 9. Creating the put
putL deletion in an HK639 prophage. A) Generation of
recombineering substrate
substrate. Lane 1 - 1Kb ladder. Lane 2 – recombineering substrate
amplified
mplified with primer set RK706 x RK707
RK707; expected size = 1.3Kb. B) Verification of the
recombination junctions. Lane 1 – Axygen 100bp ladder. Lane 2 – downstream junction,
amplified with primer set RK227 x RK 291
291; expected size = 500bp. Lane 3 – upstream
junction, amplified with primer set RK277 and RK290
RK290; expected size = 600bp. C) Map
of strain RK1319(∆putL::
L::kanR). The recombineering substrate included kanR (green
arrow).. Primers used for recombineering and junction verification are marked with tan
arrows. Predicted intrinsic transcription terminators are identified with red arrows.
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The next deletion in the series replaced base pairs 30,880-33,048 of HK639 with
the kanamycin resistance gene. Primers RK728 and RK729 were used to generate the
recombineering substrate by PCR (Figure 10). The resulting strain, designated RK1328,
was verified using primer sets RK734 x RK291 and RK570 x RK290 to amplify the
recombinant DNA junctions (Figure 11). The PCR products were sequenced to confirm
that each junction was generated as designed. A map of strain RK1328 is shown in
Figure 12.
To replace base pairs 29,152-30,887 of HK639 with the kanamycin resistance
gene, primers RK730 and RK731 were used to generate the recombineering substrate by
PCR (Figure 10). The resulting strain, designated RK1329, was verified using primer sets
RK735 x RK291 and RK736 x RK290 to amplify the recombinant DNA junctions
(Figure 11). The PCR products were sequenced to confirm that each junction was
generated as designed. A map of strain RK1329 is shown in Figure 12.
To replace base pairs 27,406-29,151 of HK639 with the kanamycin resistance
gene, primers RK732 and RK733 were used to generate the recombineering substrate by
PCR (Figure 10). The resulting strain, designated RK1330, was verified using primer sets
RK299 x RK291 and RK737 x RK290 to amplify the recombinant DNA junctions
(Figure 11). The PCR products were sequenced to confirm that each junction was
generated as designed. A map of strain RK1330 is shown in Figure 12.
To complete the deletion series, base pairs 26,022-27,406 of HK639 were
replaced with the kanamycin resistance gene. Primers RK726 and RK727 were used to
generate a recombineering substrate by PCR (Figure 10). The resulting strain, designated
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RK1332, was verified using primer sets RK742 x RK291 and RK192 x RK290 to
amplify the recombinant DNA junctions (Figure 11). The PCR products were sequenced
to confirm that each junction was generated as designed. A map of strain RK1332 is
shown in Figure 12.
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substrates for selected deletions.
deletions Lane 1 –
Figure 10. Generating the recombineering substrate
λ/HindIII Ladder. Lane 2 – recombineering substrate amplified with primer set RK728 x
RK729 for creating the deletion ((∆30,880-33,048)) in strain RK1328. Lane 3 –
recombineering substrate amplified with primer set RK730 x RK731 recombine for
creating mutant RK1329
RK1329(∆29,152-30,887). Lane 4 –recombineering
recombineering substrate amplified
with primer set RK732 x RK733 for creating mutant RK1330(∆27,406-29,151)
29,151). Lane5 –
recombineering substrate amplified
mplified with primer set RK726 x RK727 for creating mutant
RK1332(∆26,022-27,406
27,406). The expected size of each recombineering substrate was
1.3Kb.
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Figure 11. Verification of the recombination junctions of selected deletions.
deletions Lane 1, 3, 8
& 10 = 100bp ladder. Lane 2 – upstream junction (strain RK1328) amplified with primer
set RK570 x RK 290; expected size = 750bp. Lane 4 – downstream junction (strain
(
RK1328) amplified with primer set RK734 x RK291
RK291; expected size = 500bp
00bp. Lane 5 downstream junction (strain
strain RK1329) amplified with primer set RK735 x RK291;
RK291
expected size = 550bp. Lane 6 – upstream junction (strain RK1329) amplified with
primer set RK 736 x RK290
RK290; expected size= 600bp. Lane 7 – downstream junction (strain
(
RK1330) amplified with primer set RK299 x RK291
RK291; expected size = 750bp. Lane 9 –
upstream junction (strain
strain RK1330) amplified with primer set RK737 x RK290;
RK290 expected
size= 550bp. Lane 11 – upstream junction ((strain RK1332) amplified with primer set
RK192 x RK 290; expected size = 750bp. Lane 12 – downstream junction (strain
(
RK1332) amplified with primer set RK742 x RK291
RK291; expected size= 650bp.
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Figure 12.. Maps showing the location of left operon deletions. Strain RK1328(∆30,880RK1328
33,048::kanR), strain RK1329(
RK1329(∆29,152-30,887::kanR), strain RK1330(∆27,406
∆27,40629,151::kanR), and strain RK1332(
RK1332(∆26,022-27,406::kanR). The recombineering
ecombineering substrate
(kanR) is show in green.. Primers used for recom
recombineering and junction verification are
marked
arked with tan arrows. Predicted intrinsic transcription terminators are identified with
red arrows.
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The effect of deletions in the left operon of HK639 prophage
The deletions in strains RK1288(∆PL-putL::kanR), RK1319(∆putL::kanR)
RK1328(∆30,880-33,048::kanR), strain RK1329(∆29,152-30,887::kanR), strain
RK1330(∆27,406-29,151::kanR), and strain RK1332(∆26,022-27,406::kanR) were created
in an HK639 prophage. Under most circumstances, prophages will remain stably
integrated in the genome of their host. However, at a low frequency the prophage may
spontaneously enter the lytic cycle. Prophages can also be induced to enter the lytic cycle
in response to signals such as DNA damage by UV light or by chemicals such as
mitomycin C.
We used phage release assays to determine whether or not the mutant prophages
could enter the lytic cycle and produce viable phage particles. Evidence for active phage
particles can be easily visualized by spotting lysates on lawns of susceptible host cells
and looking for areas of clearing. The results of the phage release assays are shown in
Table 5.

48

Table 5. Phage release assays
Strain

Bases/Gene(s) Replaced

Phage Release

RK1288

PL & putL

No

RK1319

putL

No

RK1328

30,880-33,084

No

RK1329

29,152-30,887

No

RK1330

27,406-29,151

Yes

RK1332

26,022-27,406

No
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Our results show that removal of the promoter, PL, and the putL antitermination
sequence (strain RK1288(∆PL-putL::kanR)) or putL only (strain RK1319(∆putL::kanR))
prevents phage release. To transition from prophage to lytically growing phage, the
prophage must first excise itself from the host chromosome. This process requires
excision factors, Int and Xis, which are encoded in the left operon. The removal of the
left operon promoter (strain RK1288) was expected to prevent expression of the left
operon completely and the result is consistent with this prediction. The putL only deletion
(strain RK1319) retains a functional promoter. The inability to recover phage in this case
suggests that antitermination is essential to complete expression of the left operon.
Strains RK1328(∆30,880-33,048::kanR) and RK1329(∆29,152-30,887::kanR) also
did not release phage. The left operon promoter in each of these strains was not altered
and is assumed to be functional. The same is true for the antitermination sequences and
the excision genes. This result suggests that there is a gene(s) located in the left operon of
HK639, between 29,152bp and 33,048bp that is essential to phage growth. We do not
have independent evidence that the excision genes are actually expressed in
RK1328(∆30,880-33,048::kanR) and RK1329(∆29,152-30,887::kanR). Strain
RK1330(∆27,406-29,151::kanR) was the only mutant capable of releasing phage. This
result shows that the deleted sequences are not essential for phage excision and growth.
Strain RK1332(∆26,022-27,406::kanR) did not release phage. This was an
expected result since this deletion removed the integrase and putative excisase gene.
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Preparation of inserts for crossing left operon deletions onto lytically growing
HK639
It was previously shown that bacteriophage HK022 does not require left operon
expression for lytic phage growth (56). This was discovered when a replacement of the
HK022 left operon promoter was crossed onto a lytically growing phage. In this work, we
have replaced the left operon promoter of HK639. However, this replacement was made
in an HK639 prophage.
To determine the effect of deleting PL and putL or putL only on the lytic growth
of HK639, we attempted to cross the deletions onto an actively replicating phage. The
kanamycin resistance gene and approximately 72bp of flanking HK639 sequence was
amplified from strain RK1288 using primers RK710 and RK711. Similarly, primers
RK710 and RK738 were used to amplify the kanamycin resistance gene and
approximately 72bp of flanking HK639 sequence from strain RK1319. Successful
amplification of both deletion constructs was confirmed by analyzing the PCR products
on an agarose gel (Figure 13.A). The PCR primers were designed with incorporated
HindIII and BamHI restriction sites sequences which facilitated cloning into a similarly
digested pBR322 vector (Figure 13.B and Figure 13.C). The Ligations were
electroporated into MC1000 cells and kanamycin resistant transformants were selected on
LB plates supplemented with kanamycin (20µg/ml). Plasmid DNA from candidate clones
was purified and confirmed by sequencing the phage/plasmid junctions. Maps of the
resulting clones are shown in Figure 14.
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Figure 13. Cloning of the putL::kanR and PL-putL::kanR fusions into pBR322.
pBR322 A)
Generation of cloning inserts
inserts. Lane 1 – 100bp ladder. Lane 2 – PCR products amplified
from RK1288 (PL-putL::kkanR) with primer set RK710 x RK711. Lane 3 – PCR products
amplified from RK1319 ((putL::kanR) with primer set RK710 x RK738. The expected size
of the kanR insert =1.3Kb.
1.3Kb. B) Determining vector to insert ratios for cloning
loning the PL-putL
deletion construct (strain RK1321) into pBR322. Lane 1 - λ/HindIII
/HindIII Ladder.
Ladder Lane 2 –
PCR products (5 µl) amplified from RK1288(PL-putL::kanR), digested with BamHI &
HindIII and gel purified. Lane 3 – pBR322 (5µl), digested with BamHI and HindIII and
gel purified. C) Determining vector to insert ratios for cloning the putL::kkanR
replacement (strain RK1321
RK1321) into pBR322. Lane 1 – 100bp Ladder. Lane 2 – PCR
products (5µl) amplified from RK1319(
RK1319(putL::kanR), digested with BamHI & HindIII and
gel purified. Lane 3 – pBR322 (5µl),, digested with BamHI and HindIII and gel purified.
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Figure 14. Maps of pRK1321 and pRK1331. Primers
rs RK710 and RK711 which flank the
kanR gene (green)) were used to amplify the PL-putL::kanR construct from strain RK1288.
Regions shaded blue show areas of homology to HK639. Primers RK710 and RK738
which flank the kanR gene (green) were used to amplify the putL
L deletion from strain
RK1319(putL::kanR).
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Crossing left operon deletions onto lytically growing HK639
To cross the left operon deletions onto lytically growing HK639, infections of
strains RK1321 and RK1331 with HK639 were performed. In each case, successful
recombination would result in the transfer of the kanamycin resistance gene determinant
from the plasmid to the lytically growing HK639 by homologous recombination. The
upstream junction is identical for the kanR replacements in strains RK1321 and RK1331.
Therefore, the lysates produced from these infections were analyzed by PCR using
primer pair, RK227 and RK291 (Figure 15 and Figure 16). RK227 has homology to the
phage genome, downstream of putL, and RK291 has homology to the kanamycin
resistance gene.
Strain RK1319(∆putL::kanR) was previously confirmed to have this junction and
served as a positive control for the PCR amplifications. An HK639 wild type phage
lysate served as the negative control. Only a recombinant should produce the desired
signal (expected size = 500bp). No product of the expected size was seen in this negative
control reaction (Figure 17).
Cultures RK1321 and RK1331 were infected by mixing purified HK639 plaques
with an aliquot of host cell suspension. To maximize phage production, the host cells
were infected with a single plaque or multiple (2, 3 or 4) plaques. The lysates produced
under each of these conditions were tested for the presence of the HK639/kanR junction
using the primer set RK227 x RK291.
Recombinant phage were identified in each of the lysates as evidenced by the
appearance of a band of the expected size (Figure 15 and Figure 16). For the RK1321
lysates, the construct carrying pRK1321(∆PL-putL::kanR), the strongest signal was
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generated from the 2 plaque uninduced lysate, designated lysate 1321 (Figure 15, Lane
3). For the RK1331 lysates, the construct carrying pRK1331(∆putL::kanR), the strongest
signal was generated from the 4 plaque induced lysate, designated lysate 1331 (Figure
16, Lane 11). We attempted to isolate recombinant phage from these lysates as outlined
below.
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Figure 15. Screening
creening RK132
RK1321 lysates for recombinant phage. Lane 1 & 11 – 100bp
ladder. PCR products were amplified with primer set RK227 and RK291. The expected
size =500bp. The presence of the product indicates the presence of the HK639/kan
HK639/ R
recombination junction. Lane 2 – 1 plaque lysate. Lane 3 – 2 plaque lysate.
lysate This lysate
(circled) was chosen for additional candidate testing and was designated 1321 lysate.
Lane 4 – 3 plaque lysate. Lane 5 – 4 plaque lysate. Lane 6 - 1 plaque lysate from an
induced culture. Lane 7 – 2 plaque lysate from an induced culture. Lane 8 – 3 plaque
lysate from an induced culture
culture. Lane 9 – 4 plaque lysate from an induced culture. Lane 10
– positive control: whole
hole colony PCR from strain RK1319 using primer set RK227 x
RK291. Lane 12 – 0 plaque (cells only) control. Lane 13 – 0 plaque control (cells from
induced culture only)
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Figure 16. Screening
creening RK1331 lysates for recombinant phage. Lane 1 – 100bp ladder.
ladder
PCR products were amplified with primer set RK227 and RK291. The expected size
=500bp. The presence of the product indicates the presence of the HK639/kanR
recombination junction. Lane 2 - 0 plaque control from induced lysate. Lane 3 - 1 plaque
lysate from an induced culture
culture. Lane 4 – 2 plaque lysate from an induced culture, Lane 5
– 3 plaque lysate from an induced culture
culture. Lane 6 - 4 plaque lysate from an induced
culture. The 4 plaque lysate from an induced culture (circled) was chosen for additional
testing and was designated 1331 lysate. Lane 7 – 0 plaque lysate. Lane 8 – 1 plaque
lysate. Lane 9 – 2 plaque lysate. Lane 10 – 3 plaque lysate. Lane 11 – 4 plaque lysate.
lysate
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Figure 17. Controls to verify the specificity of PCR primers. Lane 1 – 100bp ladder, Lane
2 – HK639 lysate
ysate amplified with primer set RK227 x RK291
RK291: no amplification
lification is
expected because RK291 specifically primes within the kanR gene. Lane 3 – whole
colony PCR amplification
ation from strain RK1321using primer set RK227 x RK291:
RK291 no
amplification
tion is expected because RK291 specifically primes within the kanR. Lane 4 –
whole colony PCR from strain RK1319 using primer sett RK227 x RK291. The presence
of a product of expected size ((500bp)) indicates the presence of the HK639/kanR
recombination junction.
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Screening plaques for recombinant phage
To identify lytically growing HK639(∆PL-putL::kanR) recombinants from lysate
RK1321 and lytically growing HK639(∆putL::kanR) recombinants from lysate RK1331,
a visual inspection of plaques was performed. Lytically growing phage can be identified
by the appearance of clear plaques on a lawn of susceptible host cells. Dilutions (10-3 –
10-6) of the lysates containing recombinant phage were plated with MC1000 cells. For
lysate RK1321, the 10-3 dilution showed crowded yet distinct plaques. For lysate
RK1331, the 10-2 dilution showed crowded yet distinct plaques. Ten individual plates of a
10-3 dilution of lysate RK1321 and ten individual plates of a 10-2 dilution of the 1331
lysate were prepared. These dilutions produced the highest number of independent
plaques that could be viewed per plate. A visual inspection revealed no phenotypic
difference in the plaques; all plaques appeared turbid. This result indicates that
recombinants are either incapable of growing lytically or that the sample size was too
small.
Screening individual plaques for recombinant phages
Since no phenotypic difference of plaques was observed, we attempted to identify
recombinant phages by screening individual plaques by PCR. Plaques were picked
randomly from plates made from the 10-3 dilution of lysate RK321 and the 10-2 dilution
of lysate 1331and PCR was performed with primer set RK227 x RK291. The expected
size of the product was 500bp. No evidence of recombinant phage was observed in any of
the 1 plaque lysates (Figure 18). This result indicates that the recombinant phage are
either incapable of growing lytically or that the sample size was too small to effectively
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locate a recombinant. Another possibility is that our prediction was incorrect and the
recombinant phage are capable of producing kanamycin resistant lysogens.
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Figure 18. Screening
ing individual plaques for RK1321 recombinants. Lanes
Lane 1 & 10 –
100bp ladder. All PCR products were amplified with primer set RK227 x RK291;
RK291
expected size = 500bp. Lane 2 – plaque A. Lane 3 – plaque B. Lane 4 – plaque C.
C Lane 5
– plaque D. Lane 6 – plaque E
E. Lane 7 – plaque F. Lane 8 – plaque G. Lane 9 – plaque H.
Lane 11 – plaque I. Lane 12 – plaque J. Lane 13 – positive control: wholee colony PCR
from strain RK1319.
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Figure 19. Screening
ing individual plaques for RK1331 recombinants. Lanes 1 & 9 – 100bp
ladder. All PCR products were amplified with primer set RK227 x RK291;
RK291 expected size
= 500bp. Lane 2 – plaque A
A. Lane 3 – plaque B. Lane 4 – plaque C. Lane 5 – plaque D.
Lane 6 – plaque E. Lane 7 – plaque F. Lane 8 – plaque G. Lane 10 – plaque H.
H Lane 11 –
plaque I. Lane 12 – plaque JJ. Lane 13 - positive control: wholee colony PCR from strain
RK1319.
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Recovery of Kan resistant lysogens from RK1321 and RK1331 lysates
The surface of eight individual plaques from the RK1321 lysate and RK1331
lysate were scraped with a sterile inoculating loop and streaked on LB plates
supplemented with kanamycin (20 µg/ml). Following an overnight incubation at 37ºC,
plates were observed for the presence of kanamycin resistant colonies. We also attempted
to recover kanamycin resistant lysogens by using 10 µl aliquots of RK1321 and RK1321
lysates to infect MC1000 cells. Infections were plated on LB plates supplemented with
kanamycin (20 µg/ml) and incubated overnight at 37ºC. No kanamycin resistant colonies
were observed from either assay suggesting that either recombinants are unable to form
lysogens or that the sample size was too small and additional work is needed to identify
the recombinants.
BLAST analysis of essential gene candidates
Most of the deletions made in the early left operon of an HK639 prophage prevent
phage release. In strain RK1328, base pairs 30,880-33,048 were replaced with the
kanamycin resistance gene. Four open reading frames (orf43 – orf40) that were deleted in
this construct have no known function. The fifth open reading frame deleted in this
construct is predicted to be a phage related recombination protein. In strain, RK1329 base
pairs 29,152-30,887 were replaced with the kanamycin resistance gene. Three open
reading frames (orf38 – orf36) that were deleted in this construct have no known
function. The fourth open reading frame deleted in this construct is predicted to be an
adenine-specific methyltransferase. To determine if these open reading frames have
homology to those with known function, we analyzed these open reading frames using
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nucleotide and protein BLASTs (57). The results of this analysis are presented in Table 6
and Table 7.
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Table 6. Nucleotide BLAST results of selected HK639 open reading frames and their
homologies to other phage or bacterial sequences

Orf

Putative Function

Strain

43

None

None

42

gp38

Enterobacter cloacae subsp. cloacae ATCC
13047
Enterobacteria phage phi80

6e-71

Conserved
hypothetical
protein
FtsZ Inhibitor
protein
Conserved
hypothetical
protein
Partial
hypothetical
protein
protein of
unknown function
DUF1317
Exonuclease

Enterobacter cloacae subsp. cloacae ATCC
13047

2e-127

Enterobacter cloacae EcWSU1

8e-121

Enterobacter cloacae subsp. cloacae ATCC
13047

6e-71

Enterobacter cloacae subsp. cloacae NCTC 9394

1e-176

Enterobacter cloacae subsp. cloacae NCTC 9394

0.0

Escherichia coli str. K12 DH10B

1e-162

YqaJ viral
recombinase
family protein
Adenine-specific
methyltransferase

Enterobacteriaceae bacterium strain FGI 57

4e-52

Enterobacter cloacae subsp. cloacae ATCC
13047

9e-70

kil protein
41

40

38

37

36

e- value
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4e-53

Table 7. Protein BLAST results of selected HK639 open reading frames and their
homologies to other phage or bacterial proteins

Orf

Putative Function

Strain

e- value

43

hypothetical protein
WCE_01072

Escherichia coli KTE5

3e-117

hypothetical protein
WAW_01996

Escherichia coli KTE7

2e-26

42

hypothetical protein
HMPREF9086_1352

Enterobacter hormaechei ATCC 49162

2e-26

41

cell division protein
FtsZ

Enterobacter cloacae subsp. cloacae ATCC
13047

1e-26

40

conserved
hypothetical protein

Enterobacter cloacae subsp. cloacae ATCC
13047

1e-62

38

Siphovirus Gp157
family protein

Pantoea ananatis PA13

2e-88

37

hypothetical protein
PGS1_11786

Enterobacter cloacae subsp. cloacae GS1

3e-94

36

hypothetical protein
ECMP0215612_2610

Escherichia coli MP021561.2

7e-29

hypothetical protein
ECMP0215612_2610

Escherichia coli MP021561.2

2e-27
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DISCUSSION
Nearly a century of research effort has been dedicated to deepening our
understanding of bacteriophage biology and how they control their gene expression. The
purpose of this work was to contribute to this area of study by investigating the
requirements for transcription elongation and control of a newly discovered lambdoid
phage. Lambdoid phage are temperate, meaning they can switch between the lytic and
lysogenic lifestyles. They also have a characteristic gene organization. The early genes of
lambdoid phage are organized into two divergently transcribed operons and the
expression of all phage genes is tightly controlled.
Most lambdoid phage, ensure full expression of phage genes by suppressing
transcription termination. This process, called antitermination, was originally discovered
in λ (32). Antitermination of early gene transcription in λ is mediated by interactions
between the N protein, encoded in the left operon of the phage, the phage nut (Nutilization) sites, a copy of which is located in each operon, and host-encoded Nus (N
utilization substance) factors (34). This type of persistent antitermination is said to be
factor-dependent because readthrough of termination signals depends on the action of a
protein factor (37).
Bacteriophage HK022, a lambdoid phage, does not rely on a protein to promote
antitermination. The transcripts of the phage put (polymerase utilization) sites interact
directly with RNAP to convert it to a terminator resistant form (40). A put site is located
in each of the early operons of HK022. This model differs from the λ model because
antitermination occurs independently in the early operons.
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Bacteriophage HK639, another lambdoid phage, is unique in terms of its
requirement for antitermination. Studies have located a single intrinsic antiterminator
mechanism in the left operon of HK639 (43). This site has been shown to suppress
transcription termination and thus functions as an antiterminator RNA (43). In almost all
other examples of phage with antiterminator RNA, the put sites have been identified in
pairs, one in each early operon (43). The way HK639 controls antitermination of its right
operon is unknown.
In this study, we have presented evidence that host proteins that facilitate
antitermination in most lambdoid phages are not required for HK639 growth.
Specifically, we tested the ability of HK639 to grow on host cells that carry deletions in
the host nusA and nusG genes. These factors were chosen because the help stabilize the
transcription elongation complex and these strains were readily available to our lab.
Plaque assays were performed and EOP values were calculated (See Table 4).
The nusA deletion strain, RK1276, and nusG deletion strain, RK1277, both had
an effect on the growth of HK639 according to their EOP values. However, NusA and
NusG are essential to the growth of E. coli. NusA is a highly conserved transcription
elongation factor which modulates intrinsic (58) and Rho-dependent termination (59).
NusG enhances the transcriptional elongation rate of RNAP by suppressing
transcriptional pausing (60) and it promotes forward translocation of RNAP (61). The
deletion of either of these factors adversely affects the growth rate of E. coli cells (59).
For comparison, we determined an EOP on a strain known to block HK639
growth, strain RK899(rpoCY75N). The rpoCY75N mutant specifically blocks the
interaction between put-like RNA antiterminators and RNAP (42). The EOP value of this
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strain (≤10-7) serves as an example of a strong effect on phage growth. When compared
to the rpoCY75N mutation, the nusA and nusG deletions had little effect. We conclude
that the growth defect in the two host strains, RK1276(∆nusA) and RK1277(∆nusG)
impacted the observed EOP.
We also determined the EOP values from an additional set of nusG deletion
mutants, RK1278(∆rac) (1.66) and RK1279(∆rac,∆nusG) (1.06). The removal of rac, a
cryptic prophage from a ∆nusG mutant, restores nearly normal growth to E. coli cells. No
effect on HK639 growth was seen for the nusG deletion mutant, RK1279(∆rac,∆nusG).
Based on our results, we conclude that it is unlikely that NusA or NusG play a
primary role in the growth of bacteriophage HK639. Results from additional trials would
increase the validity of this study and testing additional Nus factor mutants (i.e. NusB,
NusE) for their ability to affect phage growth would increase our current understanding
of how host-encoded factors affect the growth of HK639.
The deletion of selected sequences in the left operon was performed to increase
our understanding of the requirements for gene expression in the left operon of HK639.
Deleting the left operon promoter, PL, and the putL antitermination sequence (RK1288)
prevented phage release as shown by phage release assay. This result underscores a
caveat of making deletions in a prophage. The factors required for prophage excision, int
and xis, are located in the left operon. The replacement of PL-putL in strain RK1288
blocked the expression of left operon genes. Consequently, the mutated prophage is
trapped within the host’s chromosome. The inability of strain RK1288(∆PL-putL::kanR)
to release phage was consistent with our expectation.
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Deleting putL (RK1319) only also prevented phage release. Since the promoter is
still functional in this construct, our results suggest that antitermination is required for the
full expression of the left operon. There are two sequential predicted Rho-independent
terminators located about 1,400 base pairs downstream of the deletion site. The activity
of these predicted Rho-independent terminators is unknown but it is unlikely that RNAP
can readthough the predicted terminator set without an intact antitermination site. Even if
the activity of the predicted terminator set is poor, the presence and location of Rhodependent terminators are unknown. These terminators are difficult to predict and cannot
easily be identified by computer analysis. It is common for terminators to be present
throughout the genomes of lambdoid phages. Therefore, we conclude that the putL
antitermination sequence is likely to be essential for the complete expression of the left
operon.
Strains RK1328(∆30,880-33,048::kanR) and RK1329(∆29,152-30,887::kanR) also
did not release phage. The promoter and antitermination sequences of these strains have
not been interrupted by these deletions and are assumed to be functional. This result
suggests that a gene(s) that is essential to phage growth, was deleted in these mutants.
Although the gene products of int and xis were not measured directly, it is assumed that
they are expressed in RK1328(∆30,880-33,048::kanR) and RK1329(∆
29,152-30,887::kanR) since neither deletion interrupted the sequences of these
genes.
We have shown that strain RK1330(∆27,406-29,151::kanR) is capable of producing
phage. The ability of this strain to produce viable phage particles shows that HK639
tolerates the replacement of ~2000 base pairs of sequence in its left operon with the
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kanamycin resistance and that the excision genes are expressed. Otherwise the prophage
would be unable to excise itself and enter the lytic cycle. This evidence also supports the
likelihood that excision genes are being expressed in RK1328(∆30,880-33,048:: kanR)
and RK1329(∆29,152-30,887::kanR) as well. We propose that there is a non-excision
related, essential gene(s) in the left operon of HK639 and that it has been replaced by the
kan resistance cassette in strain RK1328(∆30,880-33,048::kanR) and/or
RK1329(∆29,152-30,887:: kanR). Further, we conclude that no genes essential to phage
growth are located between base pairs 27,406-29,151, the location of the replacement of
RK1330.
As expected, strain RK1332 (∆26,022-27,406::kanR) which removes base pairs
26,022-27,406 of the left operon was unable to release phage. In this strain, the excision
genes, int and xis, are replaced with the kanamycin resistance gene. This strain was
designed to be a tool for identifying an int/xis complementation plasmid. Such a plasmid
should restore phage release in RK1332. We intended to use it to test left operon deletion
mutants for a defect in excision. Successful restoration of phage release would confirm
that an interruption in the expression of the excision genes is the only effect on phage
growth. This tool would enable us to make more definitive conclusions about essential
genes in the left operon of HK639.
To determine if expression of the left operon is essential to lytic growth of HK639 the
deletions made in strains RK1288(∆PL-putL::kanR) and RK1319(∆ putL::kanR) were
crossed onto lytically growing HK639. Lysates produced from growing HK639 on strain
RK1321(pRK1321 +∆PL-putL:: kanR) and RK1331(pRK1331 +∆putL:: kanR), tested
positive for the presence of recombinant phage. This was demonstrated by PCR
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amplification of and gel electrophoresis. Primer set RK227 x RK291 was used to amplify
the HK639/kanR junction. The appearance of a 500bp product from each lysate confirmed
that recombinant phage was present in the lysate.
To isolate the recombinant phage, the lysates were screened for phenotypic
differences in plaque morphology. In addition, individual plaques were screened for the
HK639/kanR junction by PCR analysis and gel electrophoresis. We also attempted to
recover lysogens of the mutant phage by infecting susceptible host cells and selecting for
kanamycin resistance. No kanamycin resistant colonies were recovered. We propose two
possible explanations. The recombination events resulted in abortive phage and there is a
non-excision related essential gene(s) located in the left operon of HK639. Or, the sample
size was too small and additional work is needed to identify a lytically growing
recombinant. The southern blotting technique, using a kanamycin resistance probe, could
be used to streamline the process of screening for recombinant phage.
We have identified open reading frames (orf42- orf40) and (orf38-orf36) as
candidates for the non-excision associated, essential gene(s) of the left operon of HK639.
We used nucleotide and protein BLAST analysis to search for putative functions for these
gene products. None of the open reading frames analyzed shared homology to any known
regulatory sequences. Our results suggest that the essential gene(s) of the left operon does
not share homology or similarity in function to any known nucleotide sequence or
protein.
Future work
Our results suggest that expression of the left operon of HK639 is necessary for
phage growth. The mutations created in this work have narrowed the search to a

72

particular location within the phage genome. The next step would be to systematically
delete the individual open reading frames that have been replaced in strains
RK1328(∆30,880-33,048:: kanR) and RK1329(∆29,152-30,887:: kanR) to precisely locate
the essential gene(s). Complementation assays should be performed to confirm the
results. Each individual open reading frame that has been deleted should be cloned into
an expression vector and introduced into its corresponding deletion mutant. Successful
complemention would be marked by the restoration of phage release in the mutant strain.
In conclusion, an investigation of its gene expression requirements has revealed
that HK639 does not depend on host encoded Nus factors for its growth. Antitermination
is necessary for expression of the left operon. There is a gene or genes located in the left
operon of HK639 that is/are essential to phage growth. Selected deletions made in the left
operon have identified ~3,000 base pairs of sequence, between base pairs 27,406-29,151,
as the predicted location of the essential gene or genes. HK639 does not appear to have
an analog to the N protein or a put like sequence in its right operon. This work provides a
platform for further exploration of the gene expression requirements for a unique
lambdoid phage, HK639.
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